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Background: Using a mobile health (mHealth) intervention consisting of a smartphone and compatible medical device has the
potential to enhance chronic obstructive pulmonary disease (COPD) treatment outcomes while mitigating health care costs.
Objective: This study aims to describe the demographics, use, and access to smartphones of patients with COPD. It also aims
to explore and develop an understanding of potential facilitators and barriers that might influence patients using mHealth
interventions for COPD management.
Methods: This was an explanatory, sequential mixed methods study. Patients who attended respirology clinics completed a
questionnaire on technology access and use. We conducted semistructured individual interviews with the patients. Interview
topics included the following: demographics, mHealth use, perceptions toward challenges of mHealth adoption, factors facilitating
mHealth adoption, and preferences regarding features of mHealth interventions for COPD management.
Results: A total of 100 adults completed the survey but 22 participants were excluded because they were not diagnosed with
COPD. Of these, 10 patients with COPD participated in the interview. The quantitative component revealed that many patients
with COPD owned a mobile phone, but only about one-fourth of the participants (18/77, 23%) owned a smartphone. The likelihood
of owning a smartphone was not associated with age, sex, marital status, or geographical location, but patients with high educational
status were more likely to own a smartphone. The qualitative component found that patients with COPD, in general, had a positive
attitude toward mHealth adoption for COPD management, but several facilitators and barriers were identified. The main facilitators
of mHealth adoption are possible health benefits for patients, ease of use, educating patients, and credibility. Alternatively, the
barriers to adoption are technical issues, lack of awareness, potential limited uptake from older adults, privacy and confidentiality
issues, finances, and lack of interest in mHealth
Conclusions: It is important to understand the perceptions of patients with COPD regarding the adoption of innovative mHealth
interventions for COPD management. This study identifies some potential facilitators and barriers that may inform the successful
development and implementation of mHealth interventions for COPD management.
(JMIR Mhealth Uhealth 2020;8(7):e17409) doi: 10.2196/17409
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Although chronic obstructive pulmonary disease (COPD) is a
preventable and treatable disease, it is currently the third leading
cause of death worldwide [1,2]. According to the Canadian
Institute for Health Information, COPD now accounts for the
highest rate of hospital admission and readmission among major
chronic illnesses in Canada [3]. The Conference Board of
Canada has stated that the combined direct and indirect costs
of COPD will increase from just under Can $4 billion (US $2.93
billion) in 2010 to Can $9.5 billion (US $6.96 billion) by 2030,
an increase of 140% [4]. These costs include direct costs
(including drugs, hospitals, and physicians) and indirect costs
(including long-term disability losses and mortality). Advances
in technology have the potential to enhance both
pharmacological and nonpharmacological interventions for
COPD management.
This surge in computing power and mobile connectivity has led
to the inception of mobile health (mHealth), which can transform
clinical research and health care [5]. mHealth is defined by the
National Institutes of Health as the “use of mobile and wireless
devices to improve health outcomes, healthcare services, and
health research.” An mHealth intervention could also include
the use of a medical device that is compatible with a smartphone.
Previous research suggests that mHealth interventions may
benefit patients with many chronic health conditions, including
COPD [6]. Some of these benefits include improving the
knowledge about COPD, increasing physical activity, and
reducing exacerbations [7-9]. Alwashmi et al [6] noted that the
current literature on the role of smartphones in reducing COPD
exacerbations is limited, but they suggest that smartphone
interventions may reduce COPD exacerbations. To potentially
enhance the adoption and outcome of mHealth interventions,
key users should be involved in the development of these
interventions.
The International Organization for Standardization (ISO)
9241-210 defines human-centered design (HCD) as “an
approach to systems design and development that aims to make
interactive systems more usable by focusing on the use of the
system and applying human factors/ergonomics and usability
knowledge and techniques” [10]. The ISO uses the term HCD
instead of user-centered design to “address impacts on a number
of stakeholders, not just those typically considered as users”
[10]. However, in practice, these terms are often used
synonymously.
Many researchers use mHealth to assist in the management of
chronic diseases; nevertheless, gaps still exist regarding the
development process of these mHealth interventions [11].
Testing mHealth interventions with patients has revealed
preferences and concerns unique to the tested population
[12-14]. Developing a COPD mHealth intervention with insights
from patients will potentially improve the process and outcome
of mHealth interventions.
Patient perspectives toward using mHealth for COPD
management are relatively unexplored [11,15]. A recent
meta-analysis on the remote monitoring of patients with COPD
concluded that some interventions may prove to be promising
in changing clinical outcomes in the future, but there are still
large gaps in the evidence base [16]. Noah et al [16] suggested
that adding a qualitative component would give researchers
insight into which elements best engage and motivate patients
and health care professionals (HCPs).
To improve the success of mHealth interventions that target
patients with COPD, we included patients in the development
process. The lessons learned will bridge the knowledge gap
between barriers and facilitators for mHealth uptake in COPD
management. Key lessons learned will be offered as a guide for
research and technology developers who are developing mHealth
interventions for COPD management [12,14,17]. Furthermore,
before implementing mHealth interventions, it is important to
understand the use of and access to mHealth.
Methods
Purpose
This study aimed to describe the demographics, use, and access
to smartphones of patients with COPD. It also aimed to assess
whether demographic factors predict engagement with mHealth
and to explore and develop an understanding of potential
facilitators and barriers that might influence patients using
mHealth interventions for COPD management.
Study Design
First, participants completed a questionnaire about technology
use and access. The findings from the questionnaire were used
to develop the sample and questions for the qualitative phase
[18]. A subset of participants were interviewed to provide deeper
insights into technology access and use among patients with
COPD. In this study, the quantitative component was fully
completed before the design and implementation of the
qualitative component. The results of the quantitative component
were used to define the qualitative sample.
Ethical Considerations
Ethical approval for this study was obtained from the
Newfoundland and Labrador Health Research Ethics Authority
(HREB-2017-194). Before agreeing to participate, all subjects
were informed about the nature of the research project, possible
risks and benefits, and their rights as research subjects. All
participants in the interview completed a written consent form
and were given a copy.
Quantitative Phase
The quantitative phase aimed to describe the demographics,
use, and access to smartphones among patients with COPD. It
also aimed to assess whether demographic factors predicted
engagement with mHealth. The results were used to define the
qualitative sample and create the questions required for the
qualitative phase.
Recruitment and Study Setting
Participants were recruited during routine visits to their
respirologists at outpatient respirology clinics in St John’s,
Newfoundland and Labrador, Canada. There are 3 clinics in the
city. Participants were eligible for the study if they met the
following inclusion criteria:
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1. A COPD diagnosis (self-report).
2. Aged ≥30 years at study enrollment.
3. Ability to answer questionnaires in English.
4. Ability to provide informed consent.
Patients who attended respirology clinics received a consent
cover letter for research. The cover letter included a
questionnaire about technology access and use (Multimedia
Appendix 1). After reading the cover letter, interested
participants completed the questionnaire and submitted it in a
locked box (red box) available at the respirology clinic.
The last section of the questionnaire included a question about
the participant’s interest in participating in an interview
regarding the same topic. Interested participants provided their
contact information and placed it in another box (blue box)
located at the respirology clinic.
We separated the contact information from the questionnaire
to ensure that the questionnaire was kept anonymous. Each
questionnaire had a unique identifier. Only the primary
investigator was able to link the questionnaire with the contact
information. The sample size (n=77) is comparable to that
reported by Granger et al [19] and Kayyali et al [20] who
assessed the use of technology among patients. Patients did not
receive remuneration for completing the questionnaire.
Data Collection
The questionnaire was adapted from Ramirez et al [21] to assess
how patients use various types of mobile technology and to
what extent they use mHealth. In addition, the questionnaire
was used to assess the need for and interest in using mobile
health technology, such as mobile phone apps and social media,
to help manage health. Similar to Ramirez et al [21] the
questionnaire was not validated due to the lack of standardized
instruments regarding the use and access to mHealth; however,
the questions were consistent with previously published
literature in the field.
The questionnaire also included demographic information such
as age, sex, race, ethnicity, primary language spoken, annual
household income, and education level. In addition, participants
were asked about their mobile phone ownership and if their
mobile phone had internet capabilities. They were also asked
if they used the internet on their mobile phones to learn about
their health. Afterward, the participants were asked about their
knowledge of mobile phone apps, if they used such apps, and
if they were currently using any mobile health apps. In addition,
participants identified individuals who they might rely on to
use mobile phones and/or mobile apps for them (eg, partner,
child, friend).
Statistical Analysis
A database of the questionnaire results was created using unique
nonidentifying numbers. The information was
password-protected. Before conducting the analysis, data were
cleaned, coded, and entered into SPSS version 25.0 (IBM
Corporation). Unclear or incomplete survey items were flagged
for queries. These were brought to the attention of the research
team, then each item was discussed, and a decision concerning
its eligibility and entry was made.
Baseline characteristics of participants were summarized with
percentages for categorical variables and means and standard
deviations for continuous variables. Crude and adjusted odds
ratios were measured using univariate and multivariable logistic
regression analyses to determine if smartphone ownership was
independently associated with age (30-64 years/65 years or
older), sex (female/male), marital status (in a relationship/not
in a relationship), education level (less than high school/high
school/more than high school), and geographical location (rural
area/small population center/medium or large population center).
All these variables have a known association with smartphone
ownership and have been previously reported in the literature
[22]. All statistical tests were performed with an alpha
significance level of .05.
Qualitative Phase
We used a descriptive qualitative research design grounded in
pragmatism [23,24]. Using a qualitative methodology allowed
us to achieve an in-depth, contextualized picture of how a
diverse sample of patients with COPD think and feel about the
possibilities and challenges of using mHealth. This has
pragmatic value, as mHealth is an emerging option for delivering
health care.
Recruitment and Study Setting
Once all the questionnaires were collected and analyzed, we
only contacted participants who agreed to participate in the
interview. On the bases of the demographic information
collected from the questionnaire, a purposeful sampling strategy
was used to identify key informants who could provide rich and
diverse interview data. We also used a criterion-based selection
[24] so that we could categorize participant characteristics such
as age, familiarity with mHealth, smartphone ownership, and
years living with COPD.
After interviewing 7 to 8 patients, we reached saturation, as we
were not gathering new information. However, we continued
interviewing until 10 patients were interviewed to strengthen
the validity of inferences [25]. Our final sample size was
comparable with similar qualitative studies [15,26].
The study was conducted in St John’s, Newfoundland and
Labrador, Canada. We conducted interviews at the Memorial
University of Newfoundland and others at the participants’
homes. Participants were recruited from April to August 2018.
After completing the interviews, participants were offered a gift
card (Can $30 [US $1.3]).
Data Collection
We conducted individual semistructured interviews to gain an
understanding of the lived experiences of patients with COPD
in relation to using mHealth [27,28]. Using semistructured
interviews allowed the interviewer to begin with a broad
question to direct the focus of the interview and then to provide
an opportunity for patients to bring forth their thoughts and
feelings about the phenomena they thought were important
[27,28]. The interview prompts are available in Multimedia
Appendix 2. If participants identified that they had not used
mHealth, they were asked questions pertaining to why they had
not used mHealth (barriers). However, we did not ask them
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about facilitators because we did not think they had the
experience needed to answer these questions. To facilitate
discussions, the interviews were conversational in nature, and
items were not asked verbatim or in the order presented. As the
study progressed, emerging issues were explored with
subsequent participants to refine the themes.
The interview questions and prompts were informed by findings
from the literature and input from the authors, who have diverse
backgrounds including in mHealth, pharmacy, nursing,
medicine, respirology, family medicine, education, and
qualitative research. They were also informed by interviewing
HCPs regarding the use of mHealth in COPD management [29].
Finally, the interview questions were informed by the results
of the quantitative phase.
The interviews were recorded to enable transparent and accurate
transcriptions. Interview lengths ranged from 20 to 40 min.
Topics included demographics, mHealth usage, perceptions
toward challenges of mHealth adoption, factors facilitating
mHealth adoption, and preferences regarding features of the
mHealth intervention for COPD management. Owing to the
large amount of data, preferences regarding features of the
mHealth intervention will be published in another article. Data
consisted of about 4 hours of interview time with approximately
100 pages of transcription.
Data Analysis
The interviews were transcribed verbatim and compared against
the digital recordings to ensure the accuracy of the content.
Identifying information (names) was removed to ensure
anonymity. We used NVivo (version 12; QSR International) to
organize the data and examine the words, including frequency
counts, as in classical content analysis [30]. All data were
analyzed, but we only coded the data that were relevant for
answering the research questions, as recommended by Saldana
[31], Wolcott [32], and Yin [33]. An audit trail was created to
keep track of all analytic decisions [34].
After using NVivo, we used first cycle coding that was both
structural and holistic [31], meaning that we used the interview
prompts and the literature to guide some of the coding. One
researcher analyzed the transcripts and developed a set of themes
and subthemes and then obtained input from a second researcher.
In the second cycle of coding, the 2 researchers independently
coded the data using pattern coding to develop themes [31].
They then discussed commonalities and differences in their
coding and theme development until consensus was reached.
Qualitative data analysis is mainly inductive as the researcher
does not approach the data with a pre-existing hypothesis that
is meant to be supported or refuted. Instead, the researcher reads
and rereads the data, using specific information to generate more
general ideas that may take the form of themes or explanations.
For this study, we had already analyzed data from health care
providers [29]. We used a deductive approach to look for patient
data that would either support or disconfirm the HCP results
from the point of view of the patients. In addition, inductive
analysis was also used to search for new ideas not mentioned
by the HCPs. The iterative process continued as these analyses
were conducted to find commonalities, differences, and new
patterns in thinking.
Mixed Methods Integration
In addition to the integration at the study design level, we
implemented integration at the methods, interpretation, and
reporting levels [35]. We implemented integration at the
methods level in 2 ways: connecting and building. Connecting
occurs when a researcher links one type of data to another type
of data through sampling [35]. In this study, we used data from
the questionnaire to purposefully sample participants for
follow-up interviews. Specifically, we were able to categorize
participant characteristics such as age, familiarity with mHealth,
smartphone ownership, and years living with COPD. Obtaining
information from a diverse group may generate a more complete
picture, reveal patterns that would otherwise go unnoticed, and
may also help identify novel relationships between variables
and concepts [18]. Building occurs when one database informs
the data collection approach of the other [35]. In this study, we
used the questionnaire responses to develop some aspects of
the interview guide. This allowed us to gain further insights
regarding mHealth use. For example, knowing if patients used
mHealth in the past was helpful in understanding the facilitators
of mHealth adoption.
Furthermore, we implemented integration at the interpretation
and reporting levels. We used both integrations through
narratives and the use of a joint display [35,36]. Integration
through a narrative occurs when a researcher describes the
quantitative and qualitative findings in a single report or series
of reports [35]. In this paper, we described the findings in a
single report and used the contiguous approach, in which
qualitative and quantitative findings are reported in different
sections. Finally, we used a joint display to provide a structure
to discuss the integrated analysis [36].
Results
A Cross-Sectional Survey of Patients
Demographics
A total of 100 adults completed the survey from January to
November 2018. Only 77 participants reported that they were
diagnosed with COPD and were included in the analysis. Table
1 provides an overview of the demographic and health
information of the sample. Table 1 indicates that most
participants were aged 55 years or older, and 61.5% had an
annual income of less than $40,000. About 70% had earned at
least a high school diploma, and there was a mixture of rural
and urban participants. Participants had a range of comorbidities,
and almost 65% were taking 5 or more medications.
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6 (8.1)Single (never married)
18 (24.3)Widowed, separated, or divorced








6 (8.8)Employed full time





14 (20.6)Less than high school







18 (25.4)Rural area (with a population less than 1000)
23 (32.4)Small population center (with a population between 1000 and 29,999)
6 (8.5)Medium population center (with a population between 30,000 and 99,999)
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12 (18.8)Skeletal or muscular disease
4 (6.3)Kidney disease






28 (41.2)More than 6
aSome patients reported several comorbidities.
mHealth Technology Ownership
Table 2 illustrates the findings regarding mHealth technology
ownership. A total of 73% (56/77) participants owned a mobile
phone, but only about one-fourth of the participants, 23%
(18/77), owned a smartphone. The number of iPad or tablet
owners was slightly higher than that of smartphones at 33%
(25/77). In terms of the availability of a smartphone in the
household, 27% (21/77) participants stated that a person in the
household owns a smartphone. Although only 23% (18/77)
participants reported having a smartphone, 29% (22/77)
participants were able to access the internet via their phone,
suggesting a higher number of smartphones than initially
reported. About a third of participants 35% (27/77) owned a
blood pressure monitor, and 22% (17/77) participants owned a
glucometer.
Logistic regression was performed to ascertain the association
of age, sex, marital status, education level, and geographical
location with the likelihood that participants owned a
smartphone. Owing to missing observations, the true sample
used in the regression was 65 of 77.
We measured crude odds ratios to determine whether
smartphone ownership was independently associated with the
occurrence of predictor variables. The likelihood of owning a
smartphone was reduced in participants earning less than a high
school diploma (crude odds ratio [cOR] 0.11, 95% CI 0.02-0.64;
P=.01) and participants earning a high school diploma (cOR
0.14, 95% CI 0.04-0.5; P=.002) compared with participants
who received education beyond high school.
The logistic regression model was statistically significant,
χ27=15.8, P=.01. The model explained 30.4% (Nagelkerke R
2)
of the variance in smartphone ownership and correctly classified
77% of cases. Sensitivity was 50%, and specificity was 89%.
Of the 5 predictor variables, only 2 were statistically significant,
and both were related to education level (as shown in Table 3).
The likelihood of owning a smartphone was reduced in
participants earning less than a high school diploma (adjusted
odds ratio [aOR] 0.12, 95% CI 0.017-0.86; P=.03) and
participants earning a high school diploma (aOR 0.13, 95% CI
0.03-0.54; P=.005) compared with participants who received
education beyond high school.
Table 2. Mobile health technology ownership (N=77).




21 (27.3)Availability of a smartphone in the household
22 (28.6)Internet access through a mobile phone
4 (5.2)Spirometer/peak flow meter
17 (22.0)Glucometer
27 (35.1)Blood pressure monitor
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Table 3. Logistic regression predicting the likelihood of smartphone ownership.








.411.63 (0.51-5.17).282.36 (0.494-11.29)In a relationshipb
N/AReferenceN/AReferenceNot in a relationshipc
Education level
.01 c0.11 (0.02-0.64).03 d0.12 (0.02-0.86)Less than high school
.002 c0.14 (0.04-0.50).005 d0.13 (0.03-0.54)High schoole
N/AReferenceN/AReferenceMore than high school
Population size
.150.35 (0.08-1.47).430.50 (0.09-2.76)Rural area
.420.61 (0.19-2.01).290.46 (0.11-1.92)Small population center
N/AReferenceN/AReferenceA medium population center or a large population center
aN/A: not applicable.
bIn a relationship includes being married or in common law.
cNot in a relationship includes being single, widowed, separated, or divorced.
dSignificance level <.05.
eHigh school includes General Educational Development.
mHealth Technology Use
Table 4 highlights the findings related to mHealth technology
use. Only a third of the participants 29% (20/77) understood
the term “app.” Of these, 50% (10/20) used apps. Among app
users, only 3/10 participants used health apps, and 7/10
participants were interested in using a health app. Six app users
said they would be comfortable allowing their family members
to access their health information, and 7 said they would be
comfortable with their HCP accessing their health care
information. The most common social media platform used was
Facebook 38% (29/77). Among users of social media, 45%
(13/29) reported using social media at least once a day.
Participants completed questions about their concerns regarding
mHealth adoption. The first question was about concerns
regarding smartphones. The following 3 options were chosen
by participants: cost of smartphones 24.5% (21/77), reducing
face-to-face interactions 20.4% (10/77), and not easy to use
18.4% (9/77). Of the participants who used apps (n=10), the
following concerns about app use were chosen: worried about
personal information disclosure (n=6), extra fees to use the app
(n=3), apps use a lot of data (n=3), apps are not easy to use
(n=1), and I do not know if they are effective (n=1). No
participants chose “taking too much time to use” or “not
recommended by a health care provider” as a concern arising
from using apps.
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Table 4. Mobile health technology use.
Values, n (%)Variables
20 (26)Understood the term “app” (n=77)a
10 (50)Use apps (n=20)b
3 (30)Use health apps (n=10)c
7 (70)Interested in using health apps (n=10)
6 (60)Comfortable allowing a family member to access health information (n=10)
7 (70)Comfortable allowing a health care provider to access health information (n=10)





9 (12)Interested in using social media to share health experience (n=77)
Frequency of social media use (n=29)d
1 (3.4)Never
5 (17.2)A few times a month
3 (10.3)A few times a week
7 (24.1)About once a day
13 (44.8)More than once a day
aTotal study population.
bSample population that understood the term “app.”
cSample population that uses apps.
dSample population that uses social media.
Semistructured Interviews With Patients
We developed themes under 2 categories: facilitators and
barriers that would influence the feasibility and use of mHealth.
We have included details and examples to illustrate patients’
thoughts and beliefs. These findings expand on the barriers and
facilitators reported previously by health care providers who
treat patients with COPD [29]. Textbox 1 highlights the
facilitators and barriers reported by patients.
Textbox 1. The facilitators and barriers to mobile health adoption.
Facilitators
1. There are possible health benefits for patients
2. The software needs to be easy to use
3. Patients need to be educated on the use of mobile health (mHealth)
4. The credibility of mHealth needs to be evident
Barriers
1. There are technical issues with mHealth
2. Lack of awareness is a challenge
3. There may be limited uptake from the elderly
4. There are possible financial barriers
5. There may be privacy and confidentiality concerns
6. There was little interest in using an mHealth intervention
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A diverse group of 10 patients with COPD participated in
face-to-face interviews. The mean age was 67.6 (SD 7.58) years,
and the range was from 51 to 80 years. There were 4 females
and 6 males. Participants stated that the mean number of years
living with COPD was 8.4 (SD 4.45), and the range was from
3 to 15 years.
Most patients expressed interest in using mHealth to assist in
the management of their COPD. In terms of smartphone
ownership, 6 participants owned a smartphone, 2 owned a
mobile phone, and 2 did not have either. Participants used their
phones for different purposes, including communication,
managing finances, gaming, and browsing the internet. One
patient stated “I use it for everything. I never thought I’d see
the day where I was dependant on my phone.” On the other
hand, another participant stated that she did not use her
smartphone beyond making phone calls: “I have a phone, but
I am not smart enough to use it.” Some participants used it to
monitor their physical activity: “I have a health thing on it and
I look at it every once in a while just to see how many steps
I’ve done that day because it...Improve health activity.” One
patient used his smartphone to “get pollen reports and anything
that will trigger a COPD attack...to do research on nutraceutical
products or on COPD-related matters.” Four participants were
enrolled in an mHealth intervention to manage their COPD.
Facilitators
Patients reported 4 facilitators, which are discussed below.
1. There Are Possible Health Benefits for Patients
Participants agreed that mHealth has the potential to provide
health benefits to patients. One patient who used a fitness tracker
remarked:
I think it’s better for me to track what I do every day.
It is going to make me feel better...That would help
me a lot with my pains...I know how my day was and
I know how I feel like.
Another patient who kept track of his vitals, weight, and
medication intake stated that:
if I had been monitored, I might not have this broken
arm...That should’ve been picked up on. I mean, I got
the records there and you look back on it, I can easily
look back on them now and say you had water
retention, your resting heart rate was way too high,
and your blood pressure was low. There’s something
wrong.
Two patients described that mHealth could provide a sense of
security and reduce hospitalization:
...it felt good to have that, you know, that security
there at least that in those four months that I had it.
So there was no guessing because you don’t know if
you should or you shouldn’t go to a hospital.
2. The Software Needs to Be Easy to Use
Usability was highlighted by many patients as an important
factor in increasing the uptake of mHealth. One patient
cautioned that he might not use an intervention if it was not
easy to use:
I’m not getting into something that’s going to fill up
my day ferreting around. But if it’s something that
I’ve got to look at for five or ten minutes, I’m okay
with that.
Participants who were enrolled in an mHealth intervention
mentioned that there was “no trouble setting up. It’s all there,
so all you had to do is turn it on.”
3. Patients Need to Be Educated on the Use of mHealth
Patients learned how to use mHealth interventions via different
sources. The majority asked their family members for assistance
“...I’ll go to my 14-year-old who is generationally more apt to
be able to teach me a new technology.” This was also mentioned
by another patient who used a fitness tracker: “My nieces. They
buy it for me and they set it up for me and everything.” Other
patients taught themselves about mHealth interventions: “If I
can read it, I can learn it...I generally research it myself” or used
the library: “Also the libraries here will help you in any
programs.” One patient said that her “...own care worker helps
with it, I don’t know how to do it.” It was also recommended
by some that technical support staff be available as a resource
for patients to call when they needed technical help.
4. The Credibility of mHealth Needs to be Evident
Some patients thought that the credibility of mHealth needs to
be made evident. Some patients stated that they would use an
mHealth intervention if it was recommended by their HCP: “if
he told me that, I probably would try to do it.” This was
reiterated by a patient who regularly monitored his COPD:
“Doctor xx was the one that said to me...If you’re going to cope
with this and keep it under control, you’re going to have to learn
how to look after yourself.”
Barriers
Patients reported 6 barriers to mHealth adoption, which are
discussed below.
1. There Are Technical Issues With mHealth
A few patients expressed that they did not have the technical
expertise to use mHealth. One patient expressed his concern:
“I wouldn’t know how to turn a computer on. I’m not very
good... You know, I never grew up with computers, but I have
seen on.” This was reiterated by another patient: “It just looked
way too complicated to download the app so I didn’t because
I’m technology averse.” For patients who used mHealth,
technical issues included limited cellular and Wi-Fi connections:
“we travel out to the cabin every weekend and the cabin’s out
in central Newfoundland out in Terra Nova and now it’s getting
better now because these phone services getting better out
there.” Another issue was moving and setting up the mHealth
intervention components, such as a blood pressure monitor or
a scale, when traveling: “...it’s not a problem. But when you go
on vacation, sometimes you got to take this along with you and
set it up somewhere.”
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2. Lack of Awareness is a Challenge
Many patients indicated that a lack of awareness is a barrier to
mHealth adoption. One patient expressed this concern: “I’m
not aware of everything that’s out there, but people need to be
more aware of their COPD and know more about it.” In addition,
a family member, who accompanied her mother in the interview,
stated the following about her mother who has COPD:
I think it’s more she probably don’t know what her
phone can do, right. But if you say to her okay we’re
going to start using this, this is going to be useful and
it’s going to be beneficial I’m sure she’d be game for
it.
However, patients who participated in an mHealth intervention
stated that their HCP recommended mHealth interventions when
they were in the hospital or attended a community health event.
Another patient mentioned that “it was advertised and I called
in about it and they got in contact with me, set me up with it.”
3. There May Be Limited Uptake by the Elderly
A few patients mentioned that they face issues in adopting
technology because of their age. One patient stated, “I’m not
generationally born into technology that is prevalent and
considered a norm of the day.” This was also mentioned by
another: “I try but I’m a little bit nervous, sometimes I’ll ask
my daughter or someone else around because we didn’t grow
up with the phones as you do today.”
4. There Are Possible Financial Barriers
A few patients said they cannot afford the costs associated with
mHealth, such as the cost of a smartphone. One patient
expressed it this way: “there’s no way I’ll pay that money.”
Expenses incurred through the use of data were also discussed:
“it’s a bit expensive for like I’ve got no data right now because
it’s all extra.” In addition to individual patient costs, one patient
raised the concern of additional costs required by HCPs:
“doctors are not going to do that without a fee.” In addition,
some mHealth programs are limited to a certain period, which
may increase costs.
5. There May Be Privacy and Confidentiality Concerns
One patient thought privacy and confidentiality could be a
barrier to mHealth adoption. She was open to sharing the results
with an HCP but not to a family member: “I don’t want to make
them worry (her family) because I told them nothing about my
cancer... I don’t like to worry my family.” The rest of the
patients were willing to share the results with their family
members and HCPs: “I don’t care who sees it...They can put it
in the Evening Telegram, doesn’t bother me.” This was echoed
by another patient: “they (his family) watch over my shoulder
like nothing else now.”
6. There Was Little Interest in Using an mHealth
Intervention
Some patients indicated that a lack of interest in mHealth is a
major barrier to its adoption. One patient expressed this concern:
“I do try to help myself but when it comes to using the phone
and that stuff and the computer, it’s not for me.” This was also
mentioned by another patient with limited technology
experience: “I know on smartphones you can dial, you can play
a game and some they can even watch movies probably, but I
got no interest.” Another patient mentioned that they are too
busy to include an mHealth intervention in their routine: “So
my day is pretty filled with different things. So remembering
is a problem. Sometimes I just say: To hell with it and I am not
going to do it. But remembering is probably the biggest thing.”
When patients use mHealth, they may share the results with
their HCP. This occurs if the mHealth intervention is not
integrated in the health care system. One patient posited that
some HCPs are not interested in reviewing the records brought




We conducted an explanatory, sequential mixed methods study
with patients and identified their perceptions regarding the use
of mHealth for COPD management. The quantitative component
revealed that over 70% of patients owned a mobile phone, but
only about a quarter of the participants (18/77, 23.4%) owned
a smartphone. The likelihood of owning a smartphone was not
associated with age, sex, marital status, or geographical location.
However, patients with a high educational status were more
likely to own a smartphone. The qualitative component found
that patients, in general, had a positive attitude toward mHealth
adoption for COPD management, but several facilitators and
barriers were identified. It is important to promote facilitators
and address the barriers to optimize the successful
implementation of mHealth interventions.
Using a mixed methods approach allowed us to produce a
diverse sample of patients with COPD. The quantitative and
qualitative components complemented each other to improve
the validity of inferences and expand on why participants
answered quantitative questions in a certain way. For example,
the number of participants who stated that they had a smartphone
(n=18) was lower than the number of participants who accessed
the internet through their mobile phone (n=22), suggesting a
lack of understanding of what a smartphone is. This was further
explored during the interviews. Although some participants
owned a smartphone, their use was limited to making phone
calls and taking pictures. On the other hand, some participants
did not own a smartphone, but they were able to enroll in an
mHealth intervention and complete the program. As explained
by one patient, “Eastern Health sets you up with everything.
It’s so different, there’s nothing to it, it’s just hit the button, use
your device and it’s so easy to use.” This finding highlights the
need for education and confidence building among patients with
COPD.
We created a joint display (Table 5) to clarify some of the
barriers that were reported quantitatively. The table is organized
by survey items. It merges the related quantitative results and
provides typical comments from patients.
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Table 5. Joint display of barriers to mobile health adoption.




Concerns regarding smartphones (N=77a)
Costs include the cost of a smartphone and the data to
enable its functionalities. However, some patients
could afford to get a smartphone, or it could be provid-
ed by the health care system
21 (27.3)Cost of smartphones • “I can’t afford one (smartphone)”
• “I’ve got no data right now because it’s all ex-
tra”
• “we can always get one (smartphone)”
Although some participants owned a smartphone, their
use was limited to making phone calls and taking pic-
tures. On the other hand, some participants did not
own a smartphone, but they were able to enroll in a
mobile health intervention and complete the program.
This finding highlights the need for education and
confidence building among patients with COPDb
9 (11.7)Not easy to use • “I wouldn’t know how to turn a computer on.
I’m not very good...”
• “There’s nothing to it, it’s just hit the button,
use your device and it’s so easy to use”
Concerns regarding app use (N=10c)
There was inconclusive evidence regarding confiden-
tiality. Patients should have a choice in what to share
and who should have access to their health information
6 (60)Worried about per-
sonal information
disclosure
• “I don’t want to make them worry because I
told them nothing about my cancer...I just told
my sister a week before I had my surgery...I
don’t like to worry my family”
• “I don’t care who sees it...They can put it in the
Evening Telegram, doesn’t bother me”
aThe total study population.
bCOPD: chronic obstructive pulmonary disease.
cThe sample population that uses apps.
Comparison With Prior Work
Our study provides a meaningful contribution to the literature,
as few prior studies have specifically examined the use of
mHealth among patients with COPD. It is important to note that
the published literature on mHealth access and use was focused
on general and largely healthy populations, with little attention
to individuals with chronic illnesses, such as COPD [37].
A study investigated smartphone ownership among the general
public and reported a high smartphone adoption rate of 76%
[20]. Ramirez et al investigated smartphone ownership in
primary care clinics and found a high adoption rate of 76%;
however, 96% of the participants were younger than 65 years.
Among patients with COPD from several locations in the United
States, we found lower smartphone adoption rates (47%), which
was double the rate reported in our sample [38]. The qualitative
data expand on this finding by clarifying that some smartphone
owners use their device in ways similar to mobile phone owners.
Knowing how to use the features of a smartphone, such as using
apps, is necessary for using the mHealth intervention. This
finding highlights the need for education and confidence
building among some smartphone users to help them use their
devices for COPD management.
Our logistic regression results support the claim that a lower
level of education is associated with limited access to mobile
devices [39-41]. Other researchers also found that the individuals
more likely to use health apps tended to be younger and have
higher incomes [38-41]. Our findings echo concerns about the
relationship between mHealth access and health disparities [38].
Limiting mHealth interventions to smartphone or tablet owners
could disproportionately benefit highly educated and wealthy
individuals.
We also investigated the association between technology use
and geographical location. Although we did not find differences
between smartphone ownership among urban and rural patients
with COPD, a report suggests that individuals living in rural
areas are less likely to have smartphones than individuals not
living in rural areas [42]. Previous studies suggest that among
patients with COPD, living in rural areas was associated with
a worse health status [43,44]. The authors suggest that the higher
prevalence of COPD in rural areas could be linked to an
increased proportion of older residents, a shortage of HCPs, the
underuse of spirometry and pulmonary rehabilitation, and
problems with access to medical care [43,44]. Limited access
to smartphones may further exacerbate health disparities for
rural patients [38].
Similar to Kayyali et al [20], the majority of the participants
were open to data-sharing options with an HCP through mHealth
apps. Nevertheless, Kayyali et al [20] stated that data sharing
can be ineffective if the participant is not honest or if data
sharing is overused.
Some of the findings presented in this study confirm previously
reported findings in the context of mHealth for COPD
management. Our findings are in agreement with those of
Vorrink et al [45], who stressed the importance of training
patients and HCPs on the proper use of mHealth. As suggested
by Korpershoek et al [15], we confirm that the expected benefits
of using mHealth contribute to the success of mHealth uptake,
and our study provides additional insight regarding these
perceptions, such as on the ease of use, educating patients about
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mHealth, and the importance of credibility. Our findings echo
some and add to the barriers reported by Krebs and Duncan
[39], which include technical difficulties and a lack of interest.
We included quotes from participants to expand on these
insights.
In comparison with the facilitators reported by HCPs, patients
had 4 parallel facilitators: there are possible health benefits for
patients, the software needs to be easy to use, patients need to
be educated on the use of mHealth, and the credibility of
mHealth should be evident [29]. The only facilitator that was
not mentioned by patients is that mHealth should reduce the
cost to the health care system. On the other hand, patients had
5 parallel barriers with the HCPs: there are technical issues with
mHealth, lack of awareness is a challenge, there may be limited
uptake from the elderly, there are possible financial barriers,
and there may be privacy and confidentiality concerns [29]. The
possibility of mHealth limiting the personal connection between
HCPs and patients was not mentioned as a barrier by patients.
Furthermore, one new barrier emerged from interviewing
patients; there was little interest in using mHealth interventions.
Our findings and the limited literature on this matter emphasize
the need for further research into the use of mHealth in COPD
management.
Strengths and Limitations
This study has several strengths. First, we used a mixed methods
approach to produce a diverse sample of participants. This
human-centered approach ensures that the needs and challenges
of a diverse group of patients can be considered before
developing an mHealth intervention. Second, some patients had
experience in using mHealth interventions to manage their
COPD, which further increases the richness of the data. Third,
all the interviews were conducted in a similar manner to ensure
consistency during data collection and analysis. Finally, we
recruited patients with COPD from outpatient respirology
clinics. This has led to the capture of a well-characterized cohort
of individuals with COPD.
There were also several limitations. First, the number of patients
who completed the survey was relatively small. However, all
efforts were made to recruit as many participants as possible
and facilitate the completion of the survey. Owing to the small
sample size, regression coefficients may have been imprecisely
estimated. However, the age of the sample was reflective of a
representative sample of patients with COPD in Canada who
were recruited from a respirology clinic [46]. Furthermore, the
main objective of the survey was to obtain a diverse sample of
patients with COPD for the qualitative phase. Second, not all
patients had experience using mHealth. Thus, the perceptions
of these participants were not based on actual interventions with
patients. Third, conducting focus groups with some of the
participants following the individual interviews could have
yielded richer information, as participants would have been
given the opportunity to compare their thoughts and confirm or
expand upon each other’s ideas. Fourth, there were no questions
in the quantitative survey about facilitators of mHealth uptake.
Including this topic would have been beneficial, as it could have
been expanded upon when conducting the interviews.
Implications for Practice and Future Research
The findings of this study may help various stakeholders who
are planning to use mHealth interventions for COPD
management. It is important to consider the low rate of
smartphone use among patients when implementing an mHealth
intervention for COPD management. Some lessons learned
include the importance of raising awareness among patients
regarding the potential of mHealth interventions in COPD
management. Family members could play a significant role in
raising awareness as well as in teaching patients with COPD
about mHealth. The findings also emphasize the importance of
developing a user-friendly mHealth intervention. This could
reduce the time and resources required to teach patients about
the mHealth intervention. The lack of an internet connection
could limit access to mHealth interventions. This should be
taken into consideration when measuring access to health
resources in rural communities. Some of the barriers and
facilitators have the potential to be applied to other chronic
diseases. For example, these findings could be beneficial for
stakeholders who plan to develop a mHealth intervention for
heart failure or diabetes.
mHealth is particularly important in geographical locations with
a relatively large proportion of rural residents such as
Newfoundland and Labrador. Of the Atlantic provinces, NL
has the highest proportion of its population (60%) living in rural
areas [47]. mHealth may enhance care provider access
throughout sparsely populated rural areas. Newfoundland and
Labrador has a substantial remote and rural population;
therefore, our results may be more applicable to rural areas.
Future studies would benefit from conducting focus groups with
some of the participants following individual interviews. Focus
groups could yield rich information, as participants would be
given the opportunity to compare their thoughts and confirm or
expand upon each other’s ideas. After developing a
user-centered mHealth intervention, the authors recommend
using a mixed methods framework for usability testing [48].
Additional trials will be required to provide data regarding the
efficacy and cost-effectiveness of mHealth interventions in
COPD management.
Conclusions
It is important to understand access to mHealth among patients
with COPD and their perceptions regarding the adoption of
mHealth for COPD management. Despite the rise in smartphone
adoption, the rate of adoption among patients with COPD
remains to be low. Additionally, it is important to consider that
owning a smartphone does not mean that one has the ability to
use it for mHealth. This finding highlights the need for education
and confidence building among some smartphone users to be
able to use their devices for COPD management. This study
identifies some potential facilitators and barriers that may inform
the successful development and implementation of mHealth
interventions for COPD management. We recommend that those
who develop mHealth interventions for COPD should consider
the facilitators and barriers highlighted in this study.
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